Brr Op Co, LLC Compugen LTD Transaction History

Brr Op Co, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 05, 2021	SELL	$5.8 - $8.02 $58,000 - $80,200	-10,000 Closed	0 $0
Q2 2020 Feb 14, 2022	BUY	$6.97 - $17.12 $69,700 - $171,200	10,000 New	10,000 $150,000
Q2 2020 Aug 13, 2020	SELL	$6.97 - $17.12 $69,700 - $171,200	-10,000 Closed	0 $0
Q1 2020 Feb 14, 2022	BUY	$5.79 - $11.83 $57,900 - $118,300	10,000 New	10,000 $73,000
Q1 2020 May 07, 2020	SELL	$5.79 - $11.83 $57,900 - $118,300	-10,000 Closed	0 $0
Q4 2019 Feb 14, 2022	BUY	$3.9 - $6.16 $39,000 - $61,600	10,000 New	10,000 $60,000
Q4 2019 Jan 31, 2020	SELL	$3.9 - $6.16 $39,000 - $61,600	-10,000 Closed	0 $0
Q3 2019 Feb 14, 2022	BUY	$3.01 - $4.49 $30,099 - $44,900	10,000 New	10,000 $42,000
Q3 2019 Nov 12, 2019	SELL	$3.01 - $4.49 $30,099 - $44,900	-10,000 Closed	0 $0
Q2 2019 Feb 14, 2022	BUY	$2.8 - $4.14 $28,000 - $41,400	10,000 New	10,000 $38,000
Q2 2019 Aug 14, 2019	SELL	$2.8 - $4.14 $28,000 - $41,400	-10,000 Closed	0 $0
Q1 2019 Feb 14, 2022	BUY	$2.35 - $4.19 $23,500 - $41,900	10,000 New	10,000 $41,000
Q1 2019 Apr 26, 2019	SELL	$2.35 - $4.19 $23,500 - $41,900	-10,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$3.0 - $4.05 $30,000 - $40,500	10,000 New	10,000 $39,000

13.1M

29.7K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $192M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Brr Op Co, LLC, based on Form 13F filings with the SEC.

Stay updated on Brr Op Co, LLC with notifications on news.